Koninklijke Philips NV ADR (PHG)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $29.66B
Last updated: Nov 17, 2026 at 11:06 AM ET
Koninklijke Philips NV ADR (PHG) Valuation Multiples
Koninklijke Philips NV ADR (PHG) trades at 1.5x sales and 2.3x book value. Its P/S of 1.5x is above its 5-year median of 1.2x.
Current Multiples
PHG reports in EUR, so earnings multiples appear here only when its per-share earnings can be confirmed. Its free cash flow yield is 8.2%.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | N/A |
| Price to sales | 1.5x |
| Price to book | 2.3x |
| EV/EBITDA | 10.0x |
| Price to FCF | 12.2x |
| EV/FCF | 14.7x |
| PEG | N/A |
| FCF yield | 8.2% |
Historical Medians
Against its 10-year medians, its P/S is 7.1% above 1.4x and its P/B is in line.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 1.5x | 1.2x | 1.4x |
| P/B | 2.3x | 1.9x | 2.3x |
Valuation History
Over the 10 year ends shown, its P/S ranged from 0.7x in 2022 to 2.3x in 2020.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $27.08 | 1.3x | 2.0x |
| 2024 | $25.32 | 1.2x | 1.9x |
| 2023 | $23.33 | 1.1x | 1.6x |
| 2022 | $14.99 | 0.7x | 1.0x |
| 2021 | $36.85 | 1.8x | 2.1x |
| 2020 | $54.17 | 2.3x | 3.6x |
| 2019 | $48.80 | 2.2x | 3.3x |
| 2018 | $35.11 | 1.6x | 2.5x |
| 2017 | $37.80 | 1.7x | 2.7x |
| 2016 | $30.57 | 1.1x | 2.3x |
P/E history is shown only for companies that report in US dollars.
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About PHG
Is PHG stock overvalued?
GNG's valuation label for PHG is Fairly valued.
What is PHG's price to sales ratio?
Koninklijke Philips NV ADR has a price to sales ratio of 1.5x.
PHG pages: Overview, Dividends, Financials, Valuation, Competitors, Government Contracts